A major UK-led study has found that undiagnosed heart failure (HF) can be detected in people with high-risk diabetes using a simple, community-based care pathway. The TARTAN-HF trial, run by the ...

President Donald Trump has signed an executive order imposing tariffs of up to 100% on imported brandname medicines, unless manufacturers sign up for drug pricing deals or set up facilities to make ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro.

California biotech Kali Therapeutics has snagged its first major pharma partner, Sanofi, which is committing $180 million in near-term payments for rights to a T-cell engager (TCE) for autoimmune ...

Eli Lilly has made a foray into the radiopharmaceuticals category with an agreement to buy POINT Biopharma for around $1.4 billion. If the $12.50-per-share all-cash deal is completed, it will give ...